Covid-19 Impact on Independent Clinical Laboratories (ICL) Market, Global Research Reports 2020-2021
- 1.4.1 Research Process
- 1.4.2 Data Triangulation
- 1.4.3 Research Approach
- 1.4.4 Base Year
- 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
- 1.5.2 Covid-19 Impact: Commodity Prices Indices
- 1.5.3 Covid-19 Impact: Global Major Government Policy
2 Global Independent Clinical Laboratories (ICL) Quarterly Market Size Analysis
- 2.1 Independent Clinical Laboratories (ICL) Business Impact Assessment - COVID-19
- 2.1.1 Global Independent Clinical Laboratories (ICL) Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
- 2.1.2 Global Independent Clinical Laboratories (ICL) Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
- 2.2 Global Independent Clinical Laboratories (ICL) Quarterly Market Size 2020-2021
- 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
- 2.3.1 Drivers
- 2.3.2 Restraints
- 2.3.3 Opportunities
- 2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
- 3.1 Global Independent Clinical Laboratories (ICL) Quarterly Market Size by Manufacturers, 2019 VS 2020
- 3.2 Global Independent Clinical Laboratories (ICL) Factory Price by Manufacturers
- 3.3 Location of Key Manufacturers Independent Clinical Laboratories (ICL) Manufacturing Factories and Area Served
- 3.4 Date of Key Manufacturers Enter into Independent Clinical Laboratories (ICL) Market
- 3.5 Key Manufacturers Independent Clinical Laboratories (ICL) Product Offered
- 3.6 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Independent Clinical Laboratories (ICL) Segments, By Type
- 4.1 Introduction
- 1.4.1 Diagnostic Testing Services
- 1.4.2 Clinical Trials Testing
- 1.4.3 Others
- 4.2 By Type, Global Independent Clinical Laboratories (ICL) Market Size, 2019-2021
- 4.2.1 By Type, Global Independent Clinical Laboratories (ICL) Market Size by Type, 2020-2021
- 4.2.2 By Type, Global Independent Clinical Laboratories (ICL) Price, 2020-2021
5 Impact of Covid-19 on Independent Clinical Laboratories (ICL) Segments, By Application
- 5.1 Overview
- 5.5.1 Enterprises
- 5.5.2 Medical Organazations
- 5.2 By Application, Global Independent Clinical Laboratories (ICL) Market Size, 2019-2021
- 5.2.1 By Application, Global Independent Clinical Laboratories (ICL) Market Size by Application, 2019-2021
- 5.2.2 By Application, Global Independent Clinical Laboratories (ICL) Price, 2020-2021
6 Geographic Analysis
- 6.1 Introduction
- 6.2 North America
- 6.2.1 Macroeconomic Indicators of US
- 6.2.2 US
- 6.2.3 Canada
- 6.3 Europe
- 6.3.1 Macroeconomic Indicators of Europe
- 6.3.2 Germany
- 6.3.3 France
- 6.3.4 UK
- 6.3.5 Italy
- 6.4 Asia-Pacific
- 6.4.1 Macroeconomic Indicators of Asia-Pacific
- 6.4.2 China
- 6.4.3 Japan
- 6.4.4 South Korea
- 6.4.5 India
- 6.4.6 ASEAN
- 6.5 Rest of World
- 6.5.1 Latin America
- 6.5.2 Middle East and Africa
7 Company Profiles
- 7.1 Quest
- 7.1.1 Quest Business Overview
- 7.1.2 Quest Independent Clinical Laboratories (ICL) Quarterly Production and Revenue, 2020
- 7.1.3 Quest Independent Clinical Laboratories (ICL) Product Introduction
- 7.1.4 Quest Response to COVID-19 and Related Developments
- 7.2 Labcorp
- 7.2.1 Labcorp Business Overview
- 7.2.2 Labcorp Independent Clinical Laboratories (ICL) Quarterly Production and Revenue, 2020
- 7.2.3 Labcorp Independent Clinical Laboratories (ICL) Product Introduction
- 7.2.4 Labcorp Response to COVID-19 and Related Developments
- 7.3 Biomnis
- 7.3.1 Biomnis Business Overview
- 7.3.2 Biomnis Independent Clinical Laboratories (ICL) Quarterly Production and Revenue, 2020
- 7.3.3 Biomnis Independent Clinical Laboratories (ICL) Product Introduction
- 7.3.4 Biomnis Response to COVID-19 and Related Developments
- 7.4 KingMed
- 7.4.1 KingMed Business Overview
- 7.4.2 KingMed Independent Clinical Laboratories (ICL) Quarterly Production and Revenue, 2020
- 7.4.3 KingMed Independent Clinical Laboratories (ICL) Product Introduction
- 7.4.4 KingMed Response to COVID-19 and Related Developments
- 7.5 Adicon
- 7.5.1 Adicon Business Overview
- 7.5.2 Adicon Independent Clinical Laboratories (ICL) Quarterly Production and Revenue, 2020
- 7.5.3 Adicon Independent Clinical Laboratories (ICL) Product Introduction
- 7.5.4 Adicon Response to COVID-19 and Related Developments
- 7.6 DAZD
- 7.6.1 DAZD Business Overview
- 7.6.2 DAZD Independent Clinical Laboratories (ICL) Quarterly Production and Revenue, 2020
- 7.6.3 DAZD Independent Clinical Laboratories (ICL) Product Introduction
- 7.6.4 DAZD Response to COVID-19 and Related Developments
- 7.7 Kindstar
- 7.7.1 Kindstar Business Overview
- 7.7.2 Kindstar Independent Clinical Laboratories (ICL) Quarterly Production and Revenue, 2020
- 7.7.3 Kindstar Independent Clinical Laboratories (ICL) Product Introduction
- 7.7.4 Kindstar Response to COVID-19 and Related Developments
- 7.8 Daan Gene
- 7.8.1 Daan Gene Business Overview
- 7.8.2 Daan Gene Independent Clinical Laboratories (ICL) Quarterly Production and Revenue, 2020
- 7.8.3 Daan Gene Independent Clinical Laboratories (ICL) Product Introduction
- 7.8.4 Daan Gene Response to COVID-19 and Related Developments
- 7.9 BML
- 7.9.1 BML Business Overview
- 7.9.2 BML Independent Clinical Laboratories (ICL) Quarterly Production and Revenue, 2020
- 7.9.3 BML Independent Clinical Laboratories (ICL) Product Introduction
- 7.9.4 BML Response to COVID-19 and Related Developments
- 7.10 SRL
- 7.10.1 SRL Business Overview
- 7.10.2 SRL Independent Clinical Laboratories (ICL) Quarterly Production and Revenue, 2020
- 7.10.3 SRL Independent Clinical Laboratories (ICL) Product Introduction
- 7.10.4 SRL Response to COVID-19 and Related Developments
- 7.11 SYNLAB
- 7.11.1 SYNLAB Business Overview
- 7.11.2 SYNLAB Independent Clinical Laboratories (ICL) Quarterly Production and Revenue, 2020
- 7.11.3 SYNLAB Independent Clinical Laboratories (ICL) Product Introduction
- 7.11.4 SYNLAB Response to COVID-19 and Related Developments
8 Supply Chain and Sales Channels Analysis
- 8.1 Independent Clinical Laboratories (ICL) Supply Chain Analysis
- 8.1.1 Independent Clinical Laboratories (ICL) Supply Chain Analysis
- 8.1.2 Covid-19 Impact on Independent Clinical Laboratories (ICL) Supply Chain
- 8.2 Distribution Channels Analysis
- 8.2.1 Independent Clinical Laboratories (ICL) Distribution Channels
- 8.2.2 Covid-19 Impact on Independent Clinical Laboratories (ICL) Distribution Channels
- 8.2.3 Independent Clinical Laboratories (ICL) Distributors
- 8.3 Independent Clinical Laboratories (ICL) Customers
9 Key Findings
10 Appendix
- 10.1 About Us
This report covers market size and forecasts of Independent Clinical Laboratories (ICL), including the following market information:
Global Independent Clinical Laboratories (ICL) Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
Global Independent Clinical Laboratories (ICL) Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
Global Independent Clinical Laboratories (ICL) Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
Global Independent Clinical Laboratories (ICL) Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)
Key market players
Major competitors identified in this market include Quest, Labcorp, Biomnis, KingMed, Adicon, DAZD, Kindstar, Daan Gene, BML, SRL, SYNLAB, etc.
Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)
Based on the Type:
Diagnostic Testing Services
Clinical Trials Testing
Others
Based on the Application:
Enterprises
Medical Organazations